Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA SUN PHARMA SAMRAT PHARMA/
SUN PHARMA
 
P/E (TTM) x 4,759.5 43.3 10,989.7% View Chart
P/BV x 1.7 7.0 23.8% View Chart
Dividend Yield % 0.3 0.7 41.7%  

Financials

 SAMRAT PHARMA   SUN PHARMA
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-23
SUN PHARMA
Mar-23
SAMRAT PHARMA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2501,072 116.6%   
Low Rs332790 42.0%   
Sales per share (Unadj.) Rs1,005.3182.9 549.6%  
Earnings per share (Unadj.) Rs53.835.7 150.8%  
Cash flow per share (Unadj.) Rs55.946.2 120.9%  
Dividends per share (Unadj.) Rs1.0011.50 8.7%  
Avg Dividend yield %0.11.2 10.2%  
Book value per share (Unadj.) Rs204.3233.4 87.6%  
Shares outstanding (eoy) m3.092,399.34 0.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.85.1 15.5%   
Avg P/E ratio x14.726.1 56.3%  
P/CF ratio (eoy) x14.120.1 70.3%  
Price / Book Value ratio x3.94.0 97.0%  
Dividend payout %1.932.2 5.8%   
Avg Mkt Cap Rs m2,4442,233,361 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1182,960 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,106438,857 0.7%  
Other income Rs m58,199 0.1%   
Total revenues Rs m3,111447,055 0.7%   
Gross profit Rs m239112,900 0.2%  
Depreciation Rs m625,294 0.0%   
Interest Rs m121,720 0.7%   
Profit before tax Rs m22594,084 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m598,476 0.7%   
Profit after tax Rs m16685,608 0.2%  
Gross profit margin %7.725.7 29.9%  
Effective tax rate %26.29.0 290.7%   
Net profit margin %5.419.5 27.4%  
BALANCE SHEET DATA
Current assets Rs m986398,619 0.2%   
Current liabilities Rs m528199,064 0.3%   
Net working cap to sales %14.845.5 32.5%  
Current ratio x1.92.0 93.4%  
Inventory Days Days8147 5.5%  
Debtors Days Days60295 632.8%  
Net fixed assets Rs m175376,960 0.0%   
Share capital Rs m312,399 1.3%   
"Free" reserves Rs m601557,555 0.1%   
Net worth Rs m631559,954 0.1%   
Long term debt Rs m00-   
Total assets Rs m1,162775,794 0.1%  
Interest coverage x19.355.7 34.6%   
Debt to equity ratio x00-  
Sales to assets ratio x2.70.6 472.8%   
Return on assets %15.411.3 136.6%  
Return on equity %26.315.3 172.3%  
Return on capital %37.617.1 220.0%  
Exports to sales %4.10-   
Imports to sales %83.30-   
Exports (fob) Rs m127NA-   
Imports (cif) Rs m2,587NA-   
Fx inflow Rs m127154,053 0.1%   
Fx outflow Rs m2,58771,511 3.6%   
Net fx Rs m-2,46082,541 -3.0%   
CASH FLOW
From Operations Rs m-9449,593 -0.2%  
From Investments Rs m-30-79,437 0.0%  
From Financial Activity Rs m9623,761 0.4%  
Net Cashflow Rs m-281,155 -2.5%  

Share Holding

Indian Promoters % 48.6 54.5 89.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.2 36.6 8.9%  
FIIs % 0.0 17.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.4 45.5 112.8%  
Shareholders   8,065 612,626 1.3%  
Pledged promoter(s) holding % 0.0 2.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on SAMRAT PHARMA vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SAMRAT PHARMA vs Sun Pharma Share Price Performance

Period SAMRAT PHARMA Sun Pharma S&P BSE HEALTHCARE
1-Day -0.26% 1.01% 1.40%
1-Month -8.65% 3.24% -0.53%
1-Year -0.85% 65.04% 62.17%
3-Year CAGR 35.15% 39.56% 18.24%
5-Year CAGR 38.54% 27.84% 19.84%

* Compound Annual Growth Rate

Here are more details on the SAMRAT PHARMA share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of SAMRAT PHARMA hold a 48.6% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SAMRAT PHARMA and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, SAMRAT PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 1.9%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of SAMRAT PHARMA, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.